Abstract
Objective
To evaluate whether liposomal prostaglandin E1 (lipo-PGE1) can decrease reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction (AMI).
Methods
Twenty-two male Chinese mini-swines were randomized into three groups: six in a sham-operation group, and eight each in the control and lipo-PGE1 groups. The distal part of the left anterior descending coronary artery (LAD) in the latter two groups was completely occluded for 2 h, and then reperfused for 3 h. Lipo-PGE1 (1 μg/kg) was injected 10 min before LAD occlusion until reperfusion for 1 h in the lipo-PGE1 group. Hemodynamic data and proinflammatory cytokines were examined before AMI, 2 h after occlusion, and 1, 2, and 3 h after reperfusion. Myocardial contrast echocardiography (MCE) and double staining were performed to evaluate the myocardial no-reflow area (NRA).
Results
Left ventricular systolic pressure and end-diastolic pressure significantly improved in the lipo-PGE1 group after reperfusion compared with the control group and also 2 h after AMI (P<0.05 for both). MCE and double staining both showed that lipo-PGE1 decreased reperfusion NRA after AMI (P<0.05, P<0.01). Lipo-PGE1 decreased serum interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) after myocardial infarction reperfusion (P<0.05 for both).
Conclusions
Lipo-PGE1 is cardioprotective in our porcine model of myocardial infarction reperfusion no-reflow, decreasing NRA and attenuating the inflammatory response.
Similar content being viewed by others
References
Fozzard, H.A., 1975. Validity of myocardial infarction models. Circulation, 52(6 Suppl.):III131–III146.
He, Z.F., Li, Z.J., 2004. Prostaglandin E1 reduces reperfusion injury of myocardium by inhibiting cytokines production during cardiac surgery. J. Zhejiang Univ. (Med. Sci.), 33(4):353–356 (in Chinese).
Jaffe, R., Charron, T., Puley, G., Dick, A., Strauss, B.H., 2008. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation, 117(24):3152–3156. [doi:10.1161/CIRCULATIONAHA.107.742312]
Kawamura, T., Nara, N., Kadosaki, M., Inada, K., Endo, S., 2000. Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. Crit. Care Med., 28(7): 2201–2208. [doi:10.1097/00003246-200007000-00004]
Krombach, G.A., Kinzel, S., Mahnken, A.H., Gunther, R.W., Buecker, A., 2005. Minimally invasive close-chest method for creating reperfused or occlusive myocardial infarction in swine. Invest. Radiol., 40(1):14–18.
Morishima, I., Sone, T., Okumura, K., Tsuboi, H., Kondo, J., Mukawa, H., Matsui, H., Toki, Y., Ito, T., Hayakawa, T., 2000. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J. Am. Coll. Cardiol., 36(4): 1202–1209. [doi:10.1016/S0735-1097(00)00865-2]
Reffelmann, T., Sensebat, O., Birnbaum, Y., Stroemer, E., Hanrath, P., Uretsky, B.F., Schwarz, E.R., 2004. A novel minimal-invasive model of chronic myocardial infarction in swine. Coronary Artery Dis., 15(1):7–12.
Smalling, R.W., Feld, S., Ramanna, N., Amirian, J., Felli, P., Vaughn, W.K., Swenson, C., Janoff, A., 1995. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model. Circulation, 92(4): 935–943.
Suzuki, Y., Lyons, J.K., Yeung, A.C., Ikeno, F., 2008. In vivo porcine model of reperfused myocardial infarction: in situ double staining to measure precise infarct area/area at risk. Catheter Cardiovasc. Interv., 71(1):100–107. [doi:10.1002/ccd.21329]
Wang, J.A., Luo, R.H., Zhang, X., Xie, X.J., Hu, X.Y., He, A.N., Chen, J., Li, J.H., 2006. Bone marrow mesenchymal stem cell transplantation combined with perindopril treatment attenuates infarction remodeling in a rat model of acute myocardial infarction. J. Zhejiang Univ.-Sci. B, 7(8):641–647. [doi:10.1631/jzus.2006.B0641]
Author information
Authors and Affiliations
Corresponding author
Additional information
Project (No. 03III02) supported by the Capital Medical Development Research Fund of China
Rights and permissions
About this article
Cite this article
Li, Jh., Yang, P., Li, Al. et al. Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow. J. Zhejiang Univ. Sci. B 12, 638–643 (2011). https://doi.org/10.1631/jzus.B1101007
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1101007